Transforming growth factor-beta: potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogenesis
- PMID: 3308784
- DOI: 10.1016/0883-2897(87)90020-1
Transforming growth factor-beta: potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogenesis
Abstract
In conclusion, we have demonstrated that a single growth factor, TGF-beta, can act in either an autocrine or paracrine mode to bring about, either directly or indirectly, all of the complex events which together lead to the formation of granulation tissue and tumor stroma. All of the participating cell types, lymphocytes, macrophages, endothelial cells, and fibroblasts have receptors for TGF-beta and many of them secrete TGF-beta as well. Although other growth factors such as platelet-derived growth factor and fibroblast growth factor clearly also participate in these processes, we have shown that TGF-beta, alone, is sufficient to initiate the cascade of events, probably through its ability to chemoattract and to activate macrophages and fibroblasts. Without question, neovascularization and appropriately timed matrix synthesis and degradation are central to embryogenesis as well. Fibronectin, in particular, has been shown to promote cell adhesion and cell migration throughout embryogenesis (Hynes and Yamada, 1982; Rovasio et al., 1983). We propose that TGF-beta will be found to be an important mediator of embryonic development, not only by control of angiogenesis and matrix synthesis, but also by exerting direct local effects on cellular growth and differentiation (reviewed in Roberts and Sporn, 1987).
Similar articles
-
The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).Eur J Surg Suppl. 1997;(577):17-23. Eur J Surg Suppl. 1997. PMID: 9076448 Review.
-
Transforming growth factor-beta: possible roles in carcinogenesis.Br J Cancer. 1988 Jun;57(6):594-600. doi: 10.1038/bjc.1988.135. Br J Cancer. 1988. PMID: 3044431 Free PMC article. Review.
-
Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms.J Cell Biol. 1989 Jul;109(1):429-40. doi: 10.1083/jcb.109.1.429. J Cell Biol. 1989. PMID: 2745556 Free PMC article.
-
Transforming growth factors and control of neoplastic cell growth.J Cell Biochem. 1987 Feb;33(2):95-107. doi: 10.1002/jcb.240330204. J Cell Biochem. 1987. PMID: 3553215 Review.
-
[The modern approach to wound treatment].Med Pregl. 2000 Jul-Aug;53(7-8):363-8. Med Pregl. 2000. PMID: 11214479 Review. Croatian.
Cited by
-
TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions.Exp Mol Med. 2010 Sep 30;42(9):606-13. doi: 10.3858/emm.2010.42.9.059. Exp Mol Med. 2010. PMID: 20631490 Free PMC article.
-
Effective prediction of preeclampsia by measuring serum angiotensin II, urinary angiotensinogen and urinary transforming growth factor β1.Exp Ther Med. 2017 Jul;14(1):391-397. doi: 10.3892/etm.2017.4484. Epub 2017 May 22. Exp Ther Med. 2017. PMID: 28672944 Free PMC article.
-
Physiologically activated mammary fibroblasts promote postpartum mammary cancer.JCI Insight. 2017 Mar 23;2(6):e89206. doi: 10.1172/jci.insight.89206. JCI Insight. 2017. PMID: 28352652 Free PMC article.
-
RANK-mediated signaling network and cancer metastasis.Cancer Metastasis Rev. 2014 Sep;33(2-3):497-509. doi: 10.1007/s10555-013-9488-7. Cancer Metastasis Rev. 2014. PMID: 24398859 Free PMC article. Review.
-
Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice.J Clin Invest. 1997 Dec 1;100(11):2697-713. doi: 10.1172/JCI119815. J Clin Invest. 1997. PMID: 9389733 Free PMC article.